Awarded
Sulfasalazin (zur Behandlung entzündlicher Gelenkerkrankungen) - DAK-G, KKH
- Winners
- Pfizer Pharma GmbH
- Contract value
- no value published
- Bids received
- 3
- Published
- 24 Aug 2026
- Awarded
- 27 Mar 2026
- Contract start
- 1 Oct 2026
- Contract end
- 30 Sept 2028stated